Lithium as a treatment of clozapine-induced neutropenia: A case report

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 8, 2008, Pages 2006-2007

  Brunoni, Andre Russowsky ^a   Kobuti Ferreira, Luiz Roberto ^a   Gallucci Neto, José ^a   Elkis, Hélio ^a   Velloso, Elvira Deolinda Pereira Rodrigues ^a   Vinicius Zanetti, Marcus ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CLOZAPINE; LITHIUM; VALPROATE SEMISODIUM;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INDUCED DISEASE; HUMAN; LETTER; MALE; MYOCLONUS SEIZURE; NEUTROPENIA; NEUTROPHIL COUNT; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN;

ADULT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; LITHIUM CHLORIDE; MALE; MENTAL DISORDERS; NEUTROPENIA;

EID: 56449128178     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.09.005     Document Type: Letter

References (15)

1. Ahn Y.M., Jeong S.H., Jang H.S., Koo Y.J., Kang U.G., and Lee K.Y. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results. Int Clin Psychopharmacol 19 (2004) 97-101
2. Bender S., Linka T., Wolstein J., Gehendges S., Paulus H.J., and Schall U. Safety and efficacy of combined clozapine-lithium pharmacotherapy. Int J Neuropsychopharmacol 7 (2004) 59-63
3. Blier P., Slater S., Measham T., Koch M., and Wiviott G. Lithium and clozapine-induced neutropenia/agranulocytosis. Int Clin Psychopharmacol 13 (1998) 137-140
4. Boshes R.A., Manschreck T.C., Desrosiers J., Candela S., and Hanrahan-Boshes M. Initiation of clozapine therapy in a patient with preexisting leukopenia: a discussion of the rationale of current treatment options. Ann Clin Psychiatry 13 (2001) 233-237
5. Chong S.A., and Remington G. Clozapine augmentation: safety and efficacy. Schizophr Bull 26 (2000) 421-440
6. Elkis H. Treatment-resistant schizophrenia. Psychiatr Clin North Am 30 (2007) 511-533
7. Esposito D., Aouille J., Rouillon F., and Limosin F. Morning pseudoneutropenia during clozapine treatment. World J Biol Psychiatry 4 (2003) 192-194
8. Esposito D., Rouillon F., and Limosin F. Continuing clozapine treatment despite neutropenia. Eur J Clin Pharmacol 60 (2005) 759-764
9. Gerson S.L., Lieberman J.A., Friedenberg W.R., Lee D., Marx Jr. J.J., and Meltzer H. Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet 338 (1991) 262-263
10. Hager E.D., Dziambor H., Winkler P., Hohmann D., and Macholdt K. Effects of lithium carbonate on hematopoietic cells in patients with persistent neutropenia following chemotherapy or radiotherapy. J Trace Elem Med Biol 16 (2002) 91-97
11. Kanaan R.A., and Kerwin R.W. Lithium and clozapine rechallenge: a retrospective case analysis. J Clin Psychiatry 67 (2006) 756-760
12. Munro J., Matthiasson P., Osborne S., Travis M., Purcell S., and Cobb A.M. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Acta Psychiatr Scand 110 (2004) 292-298
13. Valevski A., Modai I., Lahav M., and Weizman A. Clozapine-lithium combined treatment and agranulocytosis. Int Clin Psychopharmacol 8 (1993) 63-65
14. Wesson M.L., Finnegan D.M., and Clark P.I. Continuing clozapine despite neutropenia. Br J Psychiatry 168 (1996) 217-220
15. Whiskey E., and Taylor D. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities. CNS Drugs 21 (2007) 25-35